Johnson & Johnson
+Reproductive Health | September 24, 2010

Did Johnson & Johnson Bury Data on Ortho-Evra’s Health Risks?

By Meredith Melnick

It’s should be common knowledge that the Johnson & Johnson (J&J) Ortho-Evra birth-control patch has more risks than the birth control pill (it’s on the label) — because it exposes women to higher levels of hormone, it carries a higher risk of blood clots and stroke. And now an NBC report alleges that the company knew about the increased health risks before the patch ever reached market.

+Autism | February 16, 2010

“Cuddle chemical” may help alleviate autism symptoms

By Tiffany O'Callaghan

Oxytocin, a hormone often referred to as the “cuddle chemical” for its role in helping to foster intimate relationships—particularly between mothers and their newborns—may help people with autism to read and react to social cues, according to the preliminary results of a small study published in the Proceedings of the National Academy of Sciences. Individuals [...]

+Psychology | August 24, 2009

In women, testosterone is linked to risky career choice

By Laura Blue

Women with high levels of the hormone testosterone tend to be less risk averse and more likely to pick risky business careers than women with lower testosterone levels, a new study shows. Researchers from Northwestern University and the University of Chicago took saliva samples in 2006 from roughly 500 MBA students at the University of [...]

+Pharmaceuticals | August 5, 2009

A Pharma Company Role in Medical Literature

By Laura Blue

If you’ve ever worried that pharmaceutical companies have too much sway when it comes to determining your treatment, today’s news won’t help quell your fears. The New York Times reports that a large pharmaceutical developer hired ghostwriters to “play a major role in producing” 26 scientific papers that support hormone replacement therapy (HRT) in women. [...]